Merck & Co., Inc. is 14.8x more valuable than INSMED Inc by market capitalization ($294.13 B vs $19.92 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | INSM | MRK |
|---|---|---|
| Market cap | $19.92 B | $294.13 B |
| US-listed rank | #620 | #44 |
| Revenue (latest FY) | $606.42M | $65.01B |
| Net income (latest FY) | -$1.28B | $18.25B |
| Net margin | -210.5% | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 1,776 | 996 |
Merck & Co., Inc. is 14.8x more valuable than INSMED Inc by market capitalization ($294.13 B vs $19.92 B).
In their latest fiscal years, INSMED Inc reported $606.42M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: INSMED Inc and Merck & Co., Inc., or browse the full rankings.